D-0140-2020 Class II Terminated

Recalled by Macleods Pharma Usa Inc — Plainsboro, NJ

FDA drug recall D-0140-2020 was initiated by Macleods Pharma Usa Inc on Sep 23, 2019 and is designated Class II. Reason for recall: Superpotent The recall status is terminated (terminated Feb 23, 2021). Affected quantity: 31,968 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 23, 2019
Initiation Date
Sep 23, 2019
Termination Date
Feb 23, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
31,968 bottles

Product description

Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India NDC 33342-054-07

Reason for recall

Superpotent

Distribution pattern

Product was shipped to 8 distributors who may have further distributed the product.

Code information

Lot # BPF901A, exp. date 12/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0140-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0140-2020. Report a data issue: hello@regdatalab.com.